| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/05/2013 | CN103127189A Method for preparing total flavones extract product of Abelmoschl Manihot |
| 06/05/2013 | CN103127151A Application of Gypensapogenin A in medicines treating acute renal failure |
| 06/05/2013 | CN103127150A Application of Gypensapogenin B in medicines preventing and treating renal insufficiency |
| 06/05/2013 | CN103127126A 1-[4-[3-(4-morpholinyl)propoxy]-2-hydroxy phenyl]-3-(4-morpholinyl)-2-propylene-1-one and application thereof |
| 06/05/2013 | CN103127095A Synthesis and application of dihydrothiophenone derivative as pfDHODH inhibitor |
| 06/05/2013 | CN103127089A Application of Eryngiolide A in medicines curing or preventing kidney fibrosis |
| 06/05/2013 | CN103127069A Application of Eryngiolide A in medicines treating acute renal failure |
| 06/05/2013 | CN103127053A Medical application of 6-[2-(dimethylamino)ethoxy]flavone |
| 06/05/2013 | CN103127046A Medicine containing diacetyl rhein compound and preparation method of medicine |
| 06/05/2013 | CN103127030A Propylene glycol alginate sodium sulfate enteric capsule and preparation method thereof |
| 06/05/2013 | CN103127027A Polysaccharide sulphate dropping pill |
| 06/05/2013 | CN103127013A Polysaccharide sulphate lipidosome tablet |
| 06/05/2013 | CN103127004A Propylene glycol alginate sodium sulfate controlled-release granule and preparation method thereof |
| 06/05/2013 | CN102631366B Application of spirulina polysaccharides in preparation of drugs for preventing and treating male reproductive toxicity caused by organophosphorus pesticides (OPs) |
| 06/05/2013 | CN102552674B Traditional Chinese medicine medicament for treating nephrotic syndrome |
| 06/05/2013 | CN102372773B Human bladder cancer tumor marker, antibody thereof and application thereof |
| 06/05/2013 | CN102018685B Terazosin pellicle and preparation method thereof |
| 06/05/2013 | CN101998957B Substituted xanthine derivatives |
| 06/05/2013 | CN101962323B 2-acrylyl X radical-3-substituted phenyl propionate compound and purpose thereof |
| 06/05/2013 | CN101919869B Forsythoside A drug composite |
| 06/05/2013 | CN101906104B 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 06/05/2013 | CN101883781B 7P peptide and its derivant, the use thereof |
| 06/05/2013 | CN101863984B Prostatic cancer therapeutic vaccine modified on surface of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)/TNF (Tumor Necrosis Factor)-alpha membrane |
| 06/05/2013 | CN101795681B Method of preventing nephrocalcinosis |
| 06/05/2013 | CN101596308B ITGB4BP and derivates thereof used for preventing and/or treating hypertrophic scar and fibrosis lesion |
| 06/05/2013 | CN101535289B Novel phenylacetic acid derivative |
| 06/05/2013 | CN101528214B Substituted acylanilides and methods of use thereof |
| 06/05/2013 | CN101141964B Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 05/30/2013 | WO2013075607A1 Novel use of chlorogenic acid against cancer |
| 05/30/2013 | WO2013075596A1 Pentabasic dihydrogen heterocyclic ketone derivative as dhodh inhibitor and use thereof |
| 05/30/2013 | US20130137772 Hydroxypolyamine salts |
| 05/29/2013 | EP2595615A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 05/29/2013 | EP2595483A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists |
| 05/29/2013 | CN1582165B Antibodies to CD40 |
| 05/29/2013 | CN103124563A Combination therapy for the treatment of prostate carcinoma |
| 05/29/2013 | CN103124553A Phosphate binder formulation for simple ingestion |
| 05/29/2013 | CN103122300A Medicinal liquor with cold expelling and health care functions |
| 05/29/2013 | CN103122298A Magnet healthcare medicated wine |
| 05/29/2013 | CN103122297A Method for making healthcare medicinal liquor |
| 05/29/2013 | CN103122001A Polo-like kinase inhibitors |
| 05/29/2013 | CN103121973A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103120779A Fructus alpiniae oxyphyllae tablet for treating enuresis |
| 05/29/2013 | CN103120715A Traditional Chinese medicine composition for preparing medicament for prevention and treatment of focal glomeruloscerosis |
| 05/29/2013 | CN103120706A Method for preparing high-purity rutin via two-dimensional liquid chromatography-mass spectrometry combined technology |
| 05/29/2013 | CN103120682A Application of Aphanamixoid A in medicine for treating bladder cancer |
| 05/29/2013 | CN103120677A Application of Aphanamixoid A in medicine for treating or preventing renal fibrosis |
| 05/29/2013 | CN103120667A Application of Aphanamixoid A in medicine for preventing and treating renal insufficiency |
| 05/29/2013 | CN103120655A Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 05/29/2013 | CN103120652A 间苯三酚口腔崩解片及其制备方法 Among the three phenols orally disintegrating tablets and its preparation method benzene |
| 05/29/2013 | CN102370989B Medicinal composition for treating urinary system diseases |
| 05/29/2013 | CN102066327B Iminopyridine derivatives and use thereof |
| 05/29/2013 | CN101889953B Device and method for manufacturing drug smoke liquid and drug smoke |
| 05/29/2013 | CN101553491B Quinoxaline derivative |
| 05/29/2013 | CN101538218B Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/23/2013 | WO2013073382A1 Drug for treatment or prevention of nephropathy |
| 05/23/2013 | WO2013072514A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | WO2013072513A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation |
| 05/23/2013 | WO2013072512A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | WO2013072511A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | WO2013072510A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | WO2013072328A1 Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases |
| 05/23/2013 | WO2013071698A1 Three-ring pi3k and/or mtor inhibitor |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | CA2856154A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute_condition |
| 05/23/2013 | CA2856150A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | CA2856142A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizingthe circulation |
| 05/23/2013 | CA2856141A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | CA2856136A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/22/2013 | EP2594588A1 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or an anti-ADM non-Ig scaffold for use in therapy |
| 05/22/2013 | EP2594587A1 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/22/2013 | EP2594570A1 Crystal of thienopyrimidine derivative |
| 05/22/2013 | EP2594551A1 Uses of pharmaceutical-grade ferric organic compounds |
| 05/22/2013 | EP2594277A1 Tablet containing ferric citrate |
| 05/22/2013 | EP2086535B1 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 05/22/2013 | CN103119043A Fused heterocyclic compound and application thereof |
| 05/22/2013 | CN103119031A 取代酰胺化合物 Substituted amide compounds |
| 05/22/2013 | CN103113386A Nitrogen heterocycle substituting dihydroartemisinin derivative and application thereof |
| 05/22/2013 | CN103113307A 苯并咪唑类化合物及其应用 Benzimidazole compounds and their Applications |
| 05/22/2013 | CN103110944A Methods of administering anti-TNF alpha antibodies |
| 05/22/2013 | CN103110909A Traditional Chinese medicine composition for treating nephritis |
| 05/22/2013 | CN103110860A Preparation method of oral liquid of mole cricket, cricket, leech and awn of wheat |
| 05/22/2013 | CN103110853A Chinese herba preparation for treating nephrotic syndrome |
| 05/22/2013 | CN103110789A Traditional Chinese medicine composition for treating infantile enuresis |
| 05/22/2013 | CN103110770A Medicinal liquor for treating calculus |
| 05/22/2013 | CN103110765A Traditional Chinese medicine for treating renal calculi |
| 05/22/2013 | CN103110763A Traditional Chinese medicine composition for treating urinary calculus and preparation method thereof |
| 05/22/2013 | CN103110759A Preparation method of dredge pill |
| 05/22/2013 | CN103110756A Traditional Chinese medicine composition for treating renal hematuria |
| 05/22/2013 | CN103110704A Pharmaceutical composition for treating chronic prostatitis and preparation process |
| 05/22/2013 | CN103110696A Use of cinnamon oil for preparing medicine for treating prostatic hyperplasia or alopecia seborrhoeica |
| 05/22/2013 | CN103110689A Novel method for extracting astragaloside from radix astragali |
| 05/22/2013 | CN103110626A Pharmaceutical composition and application thereof |
| 05/22/2013 | CN103110617A Application of diacerein to prepare medicine for treating diabetic nephropathy |